A Biden administration plan to contain likely premium hikes for Medicare prescription drug coverage next year is raising policy questions, drawing partisan attacks, and could prompt a legal challenge.
The Medicare Part D Premium Stabilization Demonstration “will shift financial liability away from large health insurers and onto American taxpayers,” Republican lawmakers said in a letter this week seeking Congressional Budget Office review of the proposal. The conservative American Action Forum estimates the demonstration would pay drug plans $7.2 billion, making it “not so much a demonstration as it is a bailout.”
The program is designed to address likely premium increases ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.